CLC Policy Issues: Privacy


	Home \| Sitemap \| Contact Info

	Clinical Trials—Medicare \| Clinical Trials—Private Insurance \| Medicare Payment FDA \| Cancer Research \| Stem Cell Research \| Privacy \| Other


		CLC Applauds Nomination of Daschle as HHS Secretary (January 5, 2009) January 5, 2009 The Honorable Tom Daschle Health and Human Services Secretary-Designate Washington, D.C. Dear Secretary-designate Daschle: The undersigned organizations, representing cancer patients, providers and researchers throughout the country, congratulate both you and President-elect Obama on your selection as Secretary of Health and Human Services (HHS). We regard you as uniquely qualified to lead the new Administration’s health care reform efforts as proposals are formulated and proceed through the legislative process, and we look forward to working with you to improve access to health care services to everyone in the United States. Aside from the critically important goal of enhanced access, HHS faces challenges in many areas of intense interest to people with cancer. One area of primary concern is the ability of the Food and Drug Administration (FDA) to ensure the safety and quality of the nation’s food and medical products, while applying the best modern science to make new therapies available at the earliest juncture to seriously ill patients, including those with cancer. We also believe that more must be done to advance the biomedical research enterprise not only through more stable funding of the National Institutes of Health (NIH) but also through improved management and utilization of dedicated research resources. Every American’s life is touched by cancer, a disease that imposes an incredible burden economically and otherwise. There should be no higher priority for a new Administration than to advance the cause of quality cancer care for everyone who needs it, as well as support for continued research and a regulatory environment that will ensure progress against cancer in the future. Our organizations stand ready to assist you and the Obama Administration in developing and implementing a robust access, research and regulatory agenda for the benefit of all people living with, or at risk for, cancer. Sincerely, CANCER LEADERSHIP COUNCIL American Psychosocial Oncology Society American Society of Clinical Oncology American Society for Therapeutic Radiology & Oncology Bladder Cancer Advocacy Network Breast Cancer Network of Strength C3: Colorectal Cancer Coalition Cancer Care The Children's Cause for Cancer Advocacy Coalition of Cancer Cooperative Groups Gilda's Club Worldwide International Myeloma Foundation Kidney Cancer Association Lance Armstrong Foundation The Leukemia & Lymphoma Society The Lung Cancer Alliance Lymphoma Research Foundation Multiple Myeloma Research Foundation National Coalition for Cancer Survivorship National Lung Cancer Partnership National Patient Advocate Foundation North American Brain Tumor Coalition Ovarian Cancer National Alliance Pancreatic Cancer Action Network Prevent Cancer Foundation Susan G. Komen for the Cure Advocacy Alliance Us TOO International Prostate Cancer Education and Support Network The Wellness Community Back to Other Index About CLC \| What's New \| Policy Issues \| Participants' Login Home \| Sitemap \| Contact Info Copyright © 2001-2002 Cancer Leadership Council. All rights reserved. Please send comments and suggestions to webmaster@cancerleadership.org.